Outpatient-Based Therapy of Oral Fludarabine and Subcutaneous Alemtuzumab for Asian Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Background. Intravenous alemtuzumab and fludarabine are effective in combination for the treatment of chronic lymphocytic leukemia (CLL), but require hospital visits for intravenous injection. We performed a pilot study to assess the safety and efficacy of outpatient-based oral fludarabine with subc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, William Y. K., Dearden, Claire, Loh, Yvonne S. M., Linn, Yeh C., Tien, Sim L., Teoh, Gerrard K. H., How, Gee F., Heng, Kee K., Goh, Yeow T., Lee, Lai H.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778461/
https://www.ncbi.nlm.nih.gov/pubmed/19960058
http://dx.doi.org/10.1155/2009/547582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778461/
https://www.ncbi.nlm.nih.gov/pubmed/19960058
http://dx.doi.org/10.1155/2009/547582

Ejemplares similares